Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 347.82M | 356.16M | 327.74M | 412.90M | 378.43M | 319.37M |
Gross Profit | 21.16M | 3.79M | -16.81M | -9.06M | 803.00K | 17.82M |
EBITDA | 209.00K | 16.93M | 4.12M | 4.04M | 9.62M | 14.63M |
Net Income | -5.77M | -4.46M | -20.18M | -18.30M | -7.71M | -2.38M |
Balance Sheet | ||||||
Total Assets | 113.45M | 111.83M | 139.28M | 178.46M | 192.36M | 156.15M |
Cash, Cash Equivalents and Short-Term Investments | 9.91M | 12.43M | 7.77M | 25.78M | 23.68M | 15.41M |
Total Debt | 33.04M | 33.23M | 63.34M | 80.19M | 70.16M | 56.30M |
Total Liabilities | 75.67M | 75.37M | 105.84M | 123.80M | 119.73M | 114.57M |
Stockholders Equity | 37.78M | 36.47M | 33.44M | 54.66M | 72.62M | 41.58M |
Cash Flow | ||||||
Free Cash Flow | 14.50M | 26.01M | 8.24M | 9.16M | -21.92M | 4.11M |
Operating Cash Flow | 16.07M | 27.58M | 11.29M | 10.39M | -14.56M | 10.51M |
Investing Cash Flow | 1.30M | 13.17M | -577.00K | -9.93M | -5.69M | -1.82M |
Financing Cash Flow | -16.67M | -30.83M | -28.46M | -2.67M | 29.48M | -10.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $17.48B | 19.62 | 15.73% | 1.68% | 2.79% | 19.36% | |
76 Outperform | HK$151.20M | 30.00 | 4.12% | 28.15% | -17.13% | -51.35% | |
67 Neutral | HK$274.55M | 12.14 | 4.61% | 9.86% | -15.17% | -75.87% | |
65 Neutral | $10.91B | 15.53 | 5.25% | 2.19% | 3.15% | -27.00% | |
57 Neutral | HK$122.41M | ― | -6.89% | ― | 7.26% | -146.91% | |
50 Neutral | HK$698.01M | ― | -57.25% | ― | 95.39% | 30.86% | |
45 Neutral | HK$40.13M | ― | -10.20% | ― | 2.87% | 52.19% |